CBD cream shows promise for eczema itch relief in small study

NCT ID NCT07301658

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This 56-day study tested a cream containing CBD and cherimoya fruit extract on 42 children and adults with mild-to-moderate atopic dermatitis (eczema). Participants applied the cream twice daily. Researchers measured skin redness, dryness, itching, and sleep quality. The goal was to see if the cream could improve skin barrier function and comfort.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
cream containing cannabidiol (CBD) and Annona cherimola fruit extract
What this could lead to
If it works, this could offer a gentle, non-drug option to ease itching and dryness for people with mild-to-moderate atopic dermatitis.
What could go wrong
This was a small, completed study with no control group, so results may not be definitive. The cream is a cosmetic product, not a medicine, so benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • i+Med S.Coop.

    Vitoria-Gasteiz, Álava, 01510, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.